AZN:NSD-AstraZeneca PLC (USD)

COMMON STOCK | Drug Manufacturers-General | NSD

Last Closing Price

USD 58.23

Change

0.00 (0.00)%

Market Cap

USD 180.50B

Volume

0.01B

Avg Analyst Target

USD 61.97 (+6.43%)

Avg User Target

USD
Average Analyst Rating

Verdict

Fundamental Analysis

Verdict

About

AstraZeneca PLC discovers, develops, manufactures, and commercializes prescription medicines in the areas of oncology, cardiovascular, renal and metabolism, respiratory, infection, neuroscience, and gastroenterology worldwide. The company's marketed products include Tagrisso, Lynparza, Imfinzi, Enhertu, Koselugo, Lumoxiti, Equidacent, Zoladex, Faslodex, Iressa, Arimidex, Casodex/Cosudex, and others for oncology diseases; Onglyza, Bydureon, Lokelma, Byetta, Qtern, Symlin, and others for cardiovascular, renal, and metabolism diseases; and Symbicort, Pulmicort, Fasenra, Daliresp/Daxas, Duaklir, Tudorza/Eklira, Bevespi, Breztri, Anifrolumab, and others for respiratory and immunology diseases. It also offers other medicines and COVID-19 products, including Synagis, Fluenz Tetra/FluMist Quadrivalent, Seroquel IR/Seroquel XR, Vimovo, Movantik/Moventig, Nexium, Losec/Prilosec, and COVID-19 Vaccine AstraZeneca. The company serves primary care and specialty care physicians through distributors and local representative offices. It has a collaboration agreement with Daiichi Sankyo to develop and commercialize DS-1062 for the treatment of trophoblast cell-surface antigen 2 (TROP2) tumor; AliveCor, Inc. to develop non-invasive potassium monitoring solutions; Massachusetts General Hospital to accelerate digital health solutions; Sanguina on smartphone application study for hemoglobin management in patients with anemia of chronic kidney disease; Alchemab to enhance prostate cancer research; and Proteros biostructures GmbH to discover and develop novel small molecules for the treatment of various types of cancer. The company was formerly known as Zeneca Group PLC and changed its name to AstraZeneca PLC in April 1999. AstraZeneca PLC was incorporated in 1992 and is headquartered in Cambridge, the United Kingdom.

Technical Indicators

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2021-07-24 )

Largest Industry Peers for Drug Manufacturers-General

Symbol Name Price(Change) Market Cap Price / Earning Ratio EV/EBITDA
AMGN Amgen Inc

N/A

USD142.33B 20.52 12.80
SNY Sanofi

N/A

USD129.91B 9.09 8.81
GILD Gilead Sciences, Inc

N/A

USD86.56B 287.58 24.53
CELG Celgene Corporation

N/A

USD77.04B 13.33 10.62
BIIB Biogen Inc

N/A

USD48.99B 26.02 14.63
HZNP Horizon Therapeutics Public Li..

N/A

USD22.71B 80.78 40.17
GRFS Grifols, S.A

N/A

USD14.35B 31.47 15.19
GWPH GW Pharmaceuticals plc

N/A

USD6.81B 91.14 84.16

ETFs Containing AZN

Symbol Name Weight Mer Price(Change) Market Cap
ADRD Invesco BLDRS Developed M.. 0.00 % 0.30 %

N/A

USD0.02B
SPYE:F SSgA SPDR ETFs Europe II .. 0.00 % 0.25 %

N/A

USD0.39B
EXW3:F iShares STOXX Europe 50 U.. 0.00 % 0.51 %

N/A

USD5,933.95B
FLXD:F Franklin LibertyShares IC.. 0.00 % 0.25 %

N/A

USD0.03B
H4ZB:F HSBC ETFs Public Limited .. 0.00 % 0.07 %

N/A

USD0.38B
H4ZE:F HSBC ETFs Public Limited .. 0.00 % 0.20 %

N/A

USD0.15B
IQQY:F iShares II Public Limited.. 0.00 % 0.12 %

N/A

USD6.38B
IUSZ:F iShares Public Limited Co.. 0.00 % 0.07 %

N/A

USD9.50B
LYP6:F Lyxor Index Fund - Lyxor .. 0.00 % 0.07 %

N/A

USD2.29B
LYY5:F Mullti Units France - Lyx.. 0.00 % 0.25 %

N/A

USD0.90B
SLMC:F Ishares Iv Public Limited.. 0.00 % 0.12 %

N/A

USD0.43B
SLMD:F Ishares Iv Public Limited.. 0.00 % 0.12 %

N/A

USD0.43B
SPYF:F SSgA SPDR ETFs Europe I P.. 0.00 % 0.20 %

N/A

USD0.68B
EXSC:F iShares STOXX Europe Larg.. 0.00 % 0.20 %

N/A

USD5,933.98B
SPYH:F SSgA SPDR ETFs Europe II .. 0.00 % 0.23 %

N/A

USD0.59B
STXH:F Lyxor Index Fund - Lyxor .. 0.00 % 0.15 %

N/A

USD2.78B
SXR3:F iShares VII Public Limite.. 0.00 % 0.33 %

N/A

USD0.12B
SXRW:F iShares VII Public Limite.. 0.00 % 0.07 %

N/A

USD1.68B
UEF3:F UBS ETF - MSCI United Kin.. 0.00 % 0.30 %

N/A

USD0.04B
UIM3:F UBS ETF SICAV - FTSE 100 .. 0.00 % 0.20 %

N/A

USD0.08B
UIMA:F UBS ETF SICAV - MSCI Euro.. 0.00 % 0.20 %

N/A

USD0.33B
UIMF:F UBS ETF SICAV - MSCI Euro.. 0.00 % 0.30 %

N/A

N/A
XDUK:F Xtrackers - FTSE 100 UCIT.. 0.00 % 0.09 %

N/A

USD0.08B
XIEE:F Xtrackers - MSCI Europe U.. 0.00 % 0.12 %

N/A

USD0.15B
EXV4:F iShares (DE) I - iShares .. 0.00 % 0.46 %

N/A

USD0.44B
EUNK:F iShares III Public Limite.. 0.00 % 0.12 %

N/A

USD5.10B
XZEU:F Xtrackers (IE) Plc - Xtra.. 0.00 % 0.20 %

N/A

USD0.35B
UKX:PA HSBC ETFs Public Limited .. 0.00 % 0.07 %

N/A

USD0.40B
XFEW:LSE Xtrackers FTSE 100 Equal .. 0.00 % 0.25 %

N/A

USD0.02B
XZEU:LSE Xtrackers IE PLC - Xtrack.. 0.00 % 0.20 %

N/A

USD0.38B
CEU2:PA Amundi Index Solutions - .. 0.00 % 0.00 %

N/A

USD1.14B
ECN:PA BNP Paribas Easy - Low Ca.. 0.00 % 0.30 %

N/A

USD0.84B
EEUE:PA BNP Paribas Easy - MSCI E.. 0.00 % 0.00 %

N/A

USD0.06B
ERO:PA SSgA SPDR ETFs Europe II .. 0.00 % 0.25 %

N/A

USD0.39B
HEU:PA HSBC ETFs Public Limited .. 0.00 % 0.20 %

N/A

USD0.14B
MEU:PA Mullti Units France - Lyx.. 0.00 % 0.25 %

N/A

USD0.90B
MEUD:PA Lyxor Core STOXX Europe 6.. 0.00 % 0.07 %

N/A

USD2.79B
STW:PA SSgA SPDR ETFs Europe II .. 0.00 % 0.23 %

N/A

USD0.59B
10AI:F Amundi Index Solutions - .. 0.00 % 0.00 %

N/A

USD1.71B
EUN1:F iShares II Public Limited.. 0.00 % 0.35 %

N/A

USD0.54B
C068:F ComStage - STOXX® Europe.. 0.00 % 0.25 %

N/A

USD0.08B
DBXA:F Xtrackers - MSCI Europe U.. 0.00 % 0.25 %

N/A

USD3.17B
DBXX:F Xtrackers - FTSE 100 Inco.. 0.00 % 0.09 %

N/A

USD0.07B
DBXZ:F Xtrackers - FTSE All-Shar.. 0.00 % 0.18 %

N/A

USD0.04B
DX2X:F Xtrackers - Stoxx Europe .. 0.00 % 0.20 %

N/A

USD1.56B
EEUX:F BNP Paribas Easy - MSCI E.. 0.00 % 0.00 %

N/A

USD0.06B
EL42:F Deka MSCI Europe UCITS ET.. 0.00 % 0.30 %

N/A

USD0.28B
EL4H:F Deka MSCI Europe LC UCITS.. 0.00 % 0.30 %

N/A

USD0.09B
EL4Y:F Deka STOXX Europe 50 UCIT.. 0.00 % 0.19 %

N/A

USD0.25B
ELF5:F Deka MSCI Europe EX EMU U.. 0.00 % 0.30 %

N/A

USD0.46B
XSXE:F Xtrackers - Stoxx Europe .. 0.00 % 0.25 %

N/A

USD1.35B
10AI:XETRA Amundi Index Solutions - .. 0.00 % 0.00 %

N/A

USD0.16B
ZWUK:LSE BMO Enhanced Income UK Eq.. 0.00 % 0.30 %

N/A

USD0.03B
UIM3:XETRA UBS ETF SICAV - FTSE 100 .. 0.00 % 0.20 %

N/A

USD0.08B
LYP6:XETRA Lyxor Index Fund - Lyxor .. 0.00 % 0.07 %

N/A

USD2.79B
LYY5:XETRA Lyxor MSCI Europe (DR) UC.. 0.00 % 0.25 %

N/A

USD0.90B
SLMC:XETRA iShares MSCI Europe ESG S.. 0.00 % 0.12 %

N/A

USD0.90B
SLMD:XETRA iShares MSCI Europe ESG S.. 0.00 % 0.12 %

N/A

USD0.90B
SPYE:XETRA SSgA SPDR ETFs Europe II .. 0.00 % 0.25 %

N/A

USD0.39B
SPYF:XETRA SSgA SPDR ETFs Europe I P.. 0.00 % 0.20 %

N/A

USD0.68B
SPYH:XETRA SSgA SPDR ETFs Europe II .. 0.00 % 0.23 %

N/A

USD0.59B
STXH:XETRA Lyxor Index Fund - Lyxor .. 0.00 % 0.15 %

N/A

USD0.04B
SXRW:XETRA iShares VII Public Limite.. 0.00 % 0.07 %

N/A

USD1.68B
UEF3:XETRA UBS ETF - MSCI United Kin.. 0.00 % 0.30 %

N/A

USD0.04B
UIMA:XETRA UBS ETF SICAV - MSCI Euro.. 0.00 % 0.20 %

N/A

USD0.33B
LCEU:XETRA BNP Paribas Easy - Low Ca.. 0.00 % 0.30 %

N/A

USD0.85B
UIMF:XETRA UBS ETF SICAV - MSCI Euro.. 0.00 % 0.30 %

N/A

USD0.06B
VGEU:XETRA Vanguard Funds Public Lim.. 0.00 % 0.00 %

N/A

USD2.21B
VUKE:XETRA Vanguard Funds Public Lim.. 0.00 % 0.00 %

N/A

USD3.48B
XDUK:XETRA Xtrackers - FTSE 100 UCIT.. 0.00 % 0.09 %

N/A

USD0.08B
XIEE:XETRA Xtrackers - MSCI Europe U.. 0.00 % 0.12 %

N/A

USD0.15B
EXSA:XETRA iShares STOXX Europe 600 .. 0.00 % 0.20 %

N/A

USD2,635.31B
XZEU:XETRA Xtrackers IE PLC - Xtrack.. 0.00 % 0.20 %

N/A

USD0.37B
ZPRD:XETRA SPDR FTSE UK All Share UC.. 0.00 % 0.20 %

N/A

USD0.09B
1386:TSE UBS ETF MSCI Europe UCITS.. 0.00 % 0.20 %

N/A

N/A
1389:TSE UBS ETF SICAV - FTSE 100 .. 0.00 % 0.20 %

N/A

USD0.08B
LCUK:XETRA Multi Units Luxembourg - .. 0.00 % 0.04 %

N/A

USD0.25B
JREE:XETRA JPMorgan ETFs (Ireland) I.. 0.00 % 0.25 %

N/A

USD47.18B
2B70:XETRA iShares Nasdaq US Biotech.. 0.00 % 0.35 %

N/A

USD0.50B
ELF5:XETRA Deka MSCI Europe EX EMU U.. 0.00 % 0.30 %

N/A

USD0.46B
C068:XETRA ComStage - STOXX® Europe.. 0.00 % 0.25 %

N/A

USD0.08B
DBXA:XETRA Xtrackers - MSCI Europe U.. 0.00 % 0.25 %

N/A

USD2.91B
DBXX:XETRA Xtrackers - FTSE 100 Inco.. 0.00 % 0.09 %

N/A

USD0.07B
DBXZ:XETRA Xtrackers - FTSE All-Shar.. 0.00 % 0.18 %

N/A

USD0.04B
DX2X:XETRA Xtrackers - Stoxx Europe .. 0.00 % 0.20 %

N/A

USD1.59B
E960:XETRA Lyxor 1 STOXX Europe 600 .. 0.00 % 0.20 %

N/A

USD0.05B
EEUX:XETRA BNP Paribas Easy - MSCI E.. 0.00 % 0.00 %

N/A

USD0.06B
EL42:XETRA Deka MSCI Europe UCITS ET.. 0.00 % 0.30 %

N/A

USD0.28B
EL4H:XETRA Deka MSCI Europe LC UCITS.. 0.00 % 0.30 %

N/A

USD0.09B
EL4Y:XETRA Deka STOXX Europe 50 UCIT.. 0.00 % 0.19 %

N/A

USD0.25B
EUN1:XETRA iShares II Public Limited.. 0.00 % 0.35 %

N/A

USD0.54B
IUSZ:XETRA iShares Public Limited Co.. 0.00 % 0.07 %

N/A

USD9.50B
EUNA:XETRA iShares III Public Limite.. 0.00 % 0.10 %

N/A

USD1.36B
EUNK:XETRA iShares III Public Limite.. 0.00 % 0.12 %

N/A

USD5.17B
EUNZ:XETRA iShares STOXX Europe 50 U.. 0.00 % 0.35 %

N/A

USD0.44B
EXSC:XETRA iShares STOXX Europe Larg.. 0.00 % 0.20 %

N/A

USD5,933.98B
EXV4:XETRA iShares (DE) I - iShares .. 0.00 % 0.46 %

N/A

USD0.44B
EXW3:XETRA iShares STOXX Europe 50 U.. 0.00 % 0.51 %

N/A

USD5,933.95B
FLXD:XETRA Franklin LibertyQ Europea.. 0.00 % 0.25 %

N/A

USD0.02B
H4ZB:XETRA HSBC ETFs Public Limited .. 0.00 % 0.07 %

N/A

USD0.40B
H4ZE:XETRA HSBC ETFs Public Limited .. 0.00 % 0.20 %

N/A

USD0.14B
IQQY:XETRA iShares II Public Limited.. 0.00 % 0.12 %

N/A

USD6.28B
UBEU:LSE UBS ETF - MSCI Europe UCI.. 0.00 % 0.30 %

N/A

N/A
ZILK:LSE BMO MSCI UK Income Leader.. 0.00 % 0.35 %

N/A

USD4.36M
ADRU Invesco BLDRS Europe Sele.. 0.00 % 0.30 %

N/A

USD9.45M
IDEV iShares Core MSCI Interna.. 0.00 % 0.05 %

N/A

USD5.92B
VXUS Vanguard Total Internatio.. 0.00 % 0.08 %

N/A

USD404.73B
XEF:CA iShares Core MSCI EAFE IM.. 0.00 % 0.22 %

N/A

USD5.35B
XEH:CA iShares MSCI Europe IMI I.. 0.00 % 0.28 %

N/A

USD0.21B
XEU:CA iShares MSCI Europe IMI I.. 0.00 % 0.28 %

N/A

USD0.32B
XFH:CA iShares Core MSCI EAFE IM.. 0.00 % 0.22 %

N/A

USD0.79B
XIN:CA iShares MSCI EAFE Index E.. 0.00 % 0.50 %

N/A

USD1.32B
ZEA:CA BMO MSCI EAFE Index ETF 0.00 % 0.22 %

N/A

USD4.72B
HHL:CA Harvest Healthcare Leader.. 0.00 % 0.99 %

N/A

USD0.33B
MINT:CA Manulife Multifactor Deve.. 0.00 % 0.54 %

N/A

USD0.01B
LIFE:CA Evolve Global Healthcare .. 0.00 % 0.45 %

N/A

USD0.01B
JHMD John Hancock Multifactor .. 0.00 % 0.39 %

N/A

USD0.48B
VE:CA Vanguard FTSE Developed E.. 0.00 % 0.21 %

N/A

USD0.17B
DMRI DeltaShares S&P Internati.. 0.00 % 0.50 %

N/A

USD0.19B
FLEE Franklin FTSE Europe ETF 0.00 % 0.09 %

N/A

USD0.20B
MFDX PIMCO RAFI Dynamic Multi-.. 0.00 % 0.40 %

N/A

USD0.09B
FLGB Franklin FTSE United King.. 0.00 % 0.09 %

N/A

USD0.23B
FLEH Franklin FTSE Europe Hedg.. 0.00 % 0.09 %

N/A

USD0.02B
ESGD iShares ESG Aware MSCI EA.. 0.00 % 0.20 %

N/A

USD5.96B
VYMI Vanguard International Hi.. 0.00 % 0.28 %

N/A

USD2.97B
QDX:CA Mackenzie International E.. 0.00 % 0.19 %

N/A

USD0.22B
FINT:CA First Trust International.. 0.00 % 0.33 %

N/A

USD9.17M
VIDY:CA Vanguard FTSE Developed e.. 0.00 % 0.30 %

N/A

USD0.03B
VGK Vanguard FTSE Europe Inde.. 0.00 % 0.08 %

N/A

USD25.70B
TPE:CA TD International Equity I.. 0.00 % 0.20 %

N/A

USD0.98B
SDG iShares MSCI Global Impac.. 0.00 % 0.49 %

N/A

USD0.51B
EWU iShares MSCI United Kingd.. 0.00 % 0.51 %

N/A

USD3.46B
BIB ProShares Ultra Nasdaq Bi.. 0.00 % 0.95 %

N/A

USD0.27B
CNCR Loncar Cancer Immunothera.. 0.00 % 0.79 %

N/A

USD0.05B
CWI SPDR Index Shares Funds -.. 0.00 % 0.30 %

N/A

USD1.78B
DBEU Xtrackers MSCI Europe Hed.. 0.00 % 0.46 %

N/A

USD0.56B
DPK Direxion Daily MSCI Devel.. 0.00 % 1.08 %

N/A

USD0.01B
DWM WisdomTree International .. 0.00 % 0.48 %

N/A

USD0.61B
EFA iShares MSCI EAFE ETF 0.00 % 0.32 %

N/A

USD56.77B
EFO ProShares Trust - ProShar.. 0.00 % 0.95 %

N/A

USD0.01B
EFU ProShares UltraShort MSCI.. 0.00 % 0.95 %

N/A

USD1.43M
EFZ ProShares Short MSCI EAFE 0.00 % 0.95 %

N/A

USD9.64M
FEU SPDR STOXX Europe 50 ETF 0.00 % 0.29 %

N/A

USD0.18B
TLTD FlexShares Morningstar De.. 0.00 % 0.39 %

N/A

USD0.64B
GSEU Goldman Sachs ETF Trust -.. 0.00 % 0.25 %

N/A

USD0.02B
HEWU iShares Trust - iShares C.. 0.00 % 0.51 %

N/A

USD8.28M
HFXE IQ 50 Percent Hedged FTSE.. 0.00 % 0.30 %

N/A

USD8.27M
IEUR iShares Core MSCI Europe .. 0.00 % 0.09 %

N/A

USD5.18B
IEV iShares Europe ETF 0.00 % 0.59 %

N/A

USD1.88B
JPEU JPMorgan Diversified Retu.. 0.00 % 0.37 %

N/A

USD0.02B
JPIN JPMorgan Diversified Retu.. 0.00 % 0.37 %

N/A

USD0.87B
PPH VanEck Vectors ETF Trust .. 0.00 % 0.35 %

N/A

USD0.23B
RIE:CA RBC Quant EAFE Equity Lea.. 0.00 % 0.54 %

N/A

USD9.73M
RPD:CA RBC Quant European Divide.. 0.00 % 0.54 %

N/A

USD0.04B
ZGBR SPDR Solactive United Kin.. 0.00 % 0.14 %

N/A

USD0.01B
EASG Xtrackers MSCI EAFE ESG L.. 0.00 % 0.14 %

N/A

USD0.02B
XUKX:LSE Xtrackers - FTSE 100 Inco.. 0.00 % 0.09 %

N/A

USD0.07B
UKMV:LSE Ossiam Lux - Ossiam FTSE .. 0.00 % 0.45 %

N/A

USD0.95M
SMEA:LSE iShares III Public Limite.. 0.00 % 0.12 %

N/A

USD5.20B
FTAD:LSE SSgA SPDR ETFs Europe I P.. 0.00 % 0.20 %

N/A

USD0.09B
HMEU:LSE HSBC ETFs Public Limited .. 0.00 % 0.20 %

N/A

USD0.14B
JERE:LSE JPMorgan ETFs (Ireland) I.. 0.00 % 0.25 %

N/A

USD0.18B
JREE:LSE JPMorgan ETFs (Ireland) I.. 0.00 % 0.25 %

N/A

USD0.21B
LCUK:LSE Multi Units Luxembourg - .. 0.00 % 0.04 %

N/A

USD0.25B
UB03:LSE UBS ETF SICAV - FTSE 100 .. 0.00 % 0.20 %

N/A

USD0.08B
UB12:LSE UBS(Lux)Fund Solutions &#.. 0.00 % 0.20 %

N/A

USD0.33B
UC63:LSE UBS ETF SICAV - MSCI Unit.. 0.00 % 0.20 %

N/A

USD0.05B
UC64:LSE UBS ETF SICAV - MSCI Unit.. 0.00 % 0.20 %

N/A

USD1.16B
UKSR:LSE UBS (Irl) ETF Public Limi.. 0.00 % 0.28 %

N/A

USD0.69B
MEUU:LSE Mullti Units France - Lyx.. 0.00 % 0.25 %

N/A

USD0.91B
VEUD:LSE Vanguard Funds Public Lim.. 0.00 % 0.00 %

N/A

USD2.24B
VEUR:LSE Vanguard Funds Public Lim.. 0.00 % 0.00 %

N/A

USD2.21B
VUKE:LSE Vanguard Funds Public Lim.. 0.00 % 0.00 %

N/A

USD3.93B
WUKD:LSE WisdomTree UK Equity Inco.. 0.00 % 0.29 %

N/A

USD8.82M
XASX:LSE Xtrackers - FTSE All-Shar.. 0.00 % 0.18 %

N/A

USD0.04B
XDUK:LSE Xtrackers - FTSE 100 UCIT.. 0.00 % 0.09 %

N/A

USD0.08B
XEOU:LSE Xtrackers - MSCI Europe U.. 0.00 % 0.30 %

N/A

USD0.18B
XMED:LSE Xtrackers - MSCI Europe U.. 0.00 % 0.12 %

N/A

USD2.97B
XMEU:LSE Xtrackers - MSCI Europe U.. 0.00 % 0.00 %

N/A

USD2.98B
XSX6:LSE Xtrackers - Stoxx Europe .. 0.00 % 0.20 %

N/A

USD1.59B
SAEU:LSE Ishares Iv Public Limited.. 0.00 % 0.12 %

N/A

USD0.88B
MEUG:LSE Mullti Units France - Lyx.. 0.00 % 0.25 %

N/A

USD0.91B
DRFD:CA Desjardins RI Developed e.. 0.00 % 0.69 %

N/A

USD0.08B
CUKX:LSE iShares VII Public Limite.. 0.00 % 0.07 %

N/A

USD1.68B
LS:CA Middlefield Healthcare & .. 0.00 % 1.31 %

N/A

USD0.09B
GDNA Goldman Sachs Human Evolu.. 0.00 % 0.50 %

N/A

USD0.06B
XSEA:CA iShares ESG Aware MSCI EA.. 0.00 % 0.34 %

N/A

USD0.05B
USI Principal Ultra-Short Act.. 0.00 % 0.18 %

N/A

USD8.66M
INAG Innovation a Global ETF 0.00 % 0.81 %

N/A

USD1.42M
HHL-U:CA Harvest Healthcare Leader.. 0.00 % 0.99 %

N/A

N/A
SPEU SPDR Portfolio Europe ETF 0.00 % 0.09 %

N/A

N/A
BTEC:LSE iShares Nasdaq US Biotech.. 0.00 % 0.35 %

N/A

USD0.46B
BTEE:LSE iShares Nasdaq US Biotech.. 0.00 % 0.35 %

N/A

USD0.04B
CSUK:LSE iShares VII Public Limite.. 0.00 % 0.33 %

N/A

USD0.12B
ERO:LSE SSgA SPDR ETFs Europe II .. 0.00 % 0.25 %

N/A

USD0.40B
MEUD:LSE Lyxor Index Fund - Lyxor .. 0.00 % 0.07 %

N/A

USD2.80B
EUN:LSE iShares II Public Limited.. 0.00 % 0.35 %

N/A

USD0.54B
FTAL:LSE SSgA SPDR ETFs Europe I P.. 0.00 % 0.20 %

N/A

USD0.76B
HLTH:LSE SSgA SPDR ETFs Europe II .. 0.00 % 0.23 %

N/A

USD0.63B
HUKX:LSE HSBC ETFs Public Limited .. 0.00 % 0.07 %

N/A

USD0.40B
IMEA:LSE iShares Core MSCI Europe .. 0.00 % 0.12 %

N/A

USD5.10B
IMEU:LSE iShares II Public Limited.. 0.00 % 0.12 %

N/A

USD6.38B
ISEU:LSE iShares II Public Limited.. 0.00 % 0.12 %

N/A

USD6.41B
ISF:LSE iShares Public Limited Co.. 0.00 % 0.07 %

N/A

USD9.50B
ISFD:LSE iShares Public Limited Co.. 0.00 % 0.20 %

N/A

USD0.12B
ISFU:LSE iShares Public Limited Co.. 0.00 % 0.07 %

N/A

USD9.46B
1392:TSE UBS ETF MSCI United Kingd.. 0.00 % 0.20 %

N/A

N/A

Market Performance

  Market Performance vs.
Industry/Classification (Drug Manufacturers-General)
Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 16.48% 57% F 65% D
Dividend Return 1.90% 40% F 66% D
Total Return 18.38% 57% F 67% D+
Trailing 12 Months  
Capital Gain 4.35% 71% C- 26% F
Dividend Return 2.51% 20% F 45% F
Total Return 6.86% 71% C- 27% F
Trailing 5 Years  
Capital Gain 86.93% 86% B 67% D+
Dividend Return 22.31% 100% A+ 83% B
Total Return 109.25% 86% B 70% C-
Average Annual (5 Year Horizon)  
Capital Gain 15.45% 86% B 62% D-
Dividend Return 3.75% 100% A+ 81% B-
Total Return 19.20% 86% B 65% D
Risk Return Profile  
Volatility (Standard Deviation) 12.06% 71% C- 89% B+
Risk Adjusted Return 159.18% 100% A+ 99% A+
Market Capitalization 180.50B 100% A+ 99% A+
Letter Grade Percentage Letter Grade Percentage Letter Grade Percentage
A+ 97%-100% A 93%-96% A- 90%-92%
B+ 87%-89% B 83%-86% B- 80%-82%
C+ 77%-79% C 73%-76% C- 70%-72%
D+ 67%-69% D 63%-66% D- 60%-62%
F 0%-59%

Key Financial Ratios

  Ratio vs. Industry/Classification
(Drug Manufacturers-General)
Ratio vs. Market
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
Market Value  
Price / Earning Ratio 38.42 43% F 28% F
Price/Book Ratio 12.40 29% F 11% F
Price / Cash Flow Ratio 37.61 29% F 12% F
EV/EBITDA 21.37 43% F 42% F
Management Effectiveness  
Return on Equity 29.67% 86% B 93% A
Return on Invested Capital 8.85% 43% F 76% C
Return on Assets 4.19% 29% F 78% C+
Debt to Equity Ratio 112.05% 57% F 19% F
Technical Ratios  
Short Ratio 21.26 14% F 1% F
Short Percent 5.24% 14% F 36% F
Beta 0.24 86% B 91% A-
Letter Grade Percentage Letter Grade Percentage Letter Grade Percentage
A+ 97%-100% A 93%-96% A- 90%-92%
B+ 97%-89% B 83%-86% B- 80%-82%
C+ 77%-79% C 73%-76% C- 70%-72%
D+ 67%-69% D 63%-66% D- 60%-62%
F 0%-59%

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

Discussions

User / Independent Analyst Ratings

User Name Target Rating Target Horizon (Months) Target Price User Analysis Date Comment

Fundamental Analysis Breakdown

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
High market capitalization

This is one of the largest entities in its sector and is among the top quartile. Such companies tend to be more stable.

Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

Superior total returns

The stock has outperformed its sector peers on average annual total returns basis in the past 5 years (for a hold period of at least 12 months) and is in the top quartile.

High dividend returns

The stock has outperformed its sector peers on average annual dividend returns basis in the past 5 years (for a hold period of at least 12 months) and is in the top quartile. This can be a good buy, especially if it is outperforming on total return basis , for investors seeking high income yields.

Superior return on equity

The company management has delivered better return on equity in the most recent 4 quarters then its peers, placing it in the top quartile.

Positive cash flow

The company had positive total cash flow in the most recent four quarters.

Positive free cash flow

The company had positive total free cash flow in the most recent four quarters.

High Gross Profit to Asset Ratio

This stock is in the top quartile compared to its peers on Gross Profit to Asset Ratio. This is a popular measure among value investors for showing superior returns in the long run.

What to not like:
Overpriced compared to earnings

The stock is trading high compared to its peers on a price to earning basis and is above the sector median.

Overpriced compared to book value

The stock is trading high compared to its peers median on a price to book value basis.

Overpriced on cashflow basis

The stock is trading high compared to its peers on a price to cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.

Poor capital utilization

The company management has delivered below median return on invested capital in the most recent 4 quarters compared to its peers.

Poor return on assets

The company management has delivered below median return on assets in the most recent 4 quarters compared to its peers.

Overpriced on free cash flow basis

The stock is trading high compared to its peers on a price to free cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.

Low Revenue Growth

This stock has shown below median revenue growth in the previous 5 years compared to its sector

Low Dividend Growth

This stock has shown below median dividend growth in the previous 5 years compared to its sector.